TaiGen Acquires Global Rights to Late-Stage Antibiotic from Warner Chilcott – Genetic Engineering News

TaiGen Biotechnology acquired worldwide rights to the nonfluorinated quinolone antibiotic nemonoxacin from Warner Chilcott. Taiwanese firm TaiGen had previously licensed rights to nemonoxacin in 10 Asian countries, and worldwide development …